Randomized, controlled trial of telcagepant for the acute treatment of migraine. [electronic resource]
Producer: 20091113Description: 970-7 p. digitalISSN:- 1526-632X
- Acute Disease
- Adult
- Azepines -- administration & dosage
- Calcitonin Gene-Related Peptide -- antagonists & inhibitors
- Calcitonin Gene-Related Peptide Receptor Antagonists
- Dose-Response Relationship, Drug
- Double-Blind Method
- Endpoint Determination
- Female
- Humans
- Hyperacusis -- drug therapy
- Imidazoles -- administration & dosage
- Male
- Middle Aged
- Migraine Disorders -- drug therapy
- Nausea -- etiology
- Outcome Assessment, Health Care
- Pain Measurement
- Photophobia -- drug therapy
- Placebos
- Quality of Life
- Receptors, Calcitonin Gene-Related Peptide -- metabolism
- Surveys and Questionnaires
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.